https://www.selleckchem.com/pr....oducts/piceatannol.h
en to identify the most effective non-pharmacological intervention for depressive disorder after TBI. Our work could be used to give clinical recommendations for practice guideline developers, psychiatrist, neurologist, policymakers, researchers as well as individual with depressive disorder after TBI, and will also identify gaps in knowledge that could be the subject of future research. Neither ethics approval nor patient informed consent is necessary since this protocol was designed based on the existing literature. The results wi
Me gusta
Comentario
Compartir
